Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents A protocol for systematic review and meta-analysis
<h3>Introduction</h3><p dir="ltr">Existing evidence on the difference in the incidence of tumor lysis syndrome (TLS) in Chronic Lymphocytic Leukemia (CLL) patients receiving novel therapies versus patients receiving conventional therapies is limited and inconclusive. The...
محفوظ في:
| المؤلف الرئيسي: | Nancy Kassem (3517106) (author) |
|---|---|
| مؤلفون آخرون: | Ahmed A. Ghazy (16555849) (author), Mohammad Abu-Tineh (14829313) (author), Nabil E. Omar (16555850) (author), Abdulqadir J. Nashwan (16328993) (author), Prem Chandra (9072038) (author), Rola Ghasoub (16555851) (author), Osama S. AbuTabar (16555854) (author), Mohamed A. Yassin (16322749) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs) and Ultrasound.
حسب: Ibrahim, Mihad
منشور في: (2016) -
Biologic characterization of atypical chronic lymphocytic leukaemia
حسب: Dina S. Soliman (14779333)
منشور في: (2021) -
The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
حسب: Maria Benkhadra (19756941)
منشور في: (2024) -
Spontaneous tumor lysis syndrome in a patient with accelerated phase chronic myeloid leukemia treated successfully with rasburicase
حسب: Abdulrahman F. Al-Mashdali (17148316)
منشور في: (2022) -
Revolutionizing chronic lymphocytic leukemia diagnosis: A deep dive into the diverse applications of machine learning
حسب: Mohamed Elhadary (16329082)
منشور في: (2023)